We envision that our ACE2-containing LSC-Exo could serve as a convenient and cost-effective agent to prevent initial infection or further internal dissemination of the virus, reduce viral transmission and alleviate disease onset of COVID-19. The gene discussed is ACE2; the disease is COVID-19.